Reduced-intensity conditioning (RIC) allo-SCT is a potentially curative treatment approach for patients with relapsed Hodgkin’s or non-Hodgkin’s lymphoma. In the present study, 37 patients underwent ...

A study supports targeted conversion of kidney transplant recipients with a history of cutaneous squamous cell carcinoma ...

Acute GVHD (aGVHD) is a major cause of morbidity and mortality in hematopoietic allograft recipients. The best therapy for patients failing to respond, or not tolerating, systemic glucocorticoids ...

The two medications can be administered concomitantly if various factors are taken into account. CHICAGO—Clinicians can safely use sirolimus and voriconazole concurrently if certain steps are followed ...

Please provide your email address to receive an email when new articles are posted on . One glass of grapefruit juice each day significantly slowed the body’s metabolism of sirolimus, suggesting ...

Please provide your email address to receive an email when new articles are posted on . Four of six patients who used sirolimus had positive responses and discontinued systemic corticosteroids. Three ...

Background: Sirolimus-eluting stents have recently been shown to reduce the risk of restenosis among patients who undergo percutaneous coronary intervention (PCI). Given that sirolimus-eluting stents ...

For the first time, a product is available specifically for use in patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumors. The product is an ...

Sirolimus, when used instead of calcineurin inhibitors in transplant patients, could reduce the incidence and delay the occurrence of a repeat squamous-cell cancer of the skin, according to a recent ...

Preliminary reports of studies involving simple coronary lesions indicate that a sirolimus-eluting stent significantly reduces the risk of restenosis after percutaneous coronary revascularization. We ...

Newark, May 22, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 250 million in 2023 global sirolimus market will reach USD 370.06 million in 2033. Sirolimus is also known as ...